Stuart Chaussee & Associates’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-500
Closed -$36K 121
2017
Q3
$36K Sell
500
-520
-51% -$37.5K 0.03% 42
2017
Q2
$76K Sell
1,020
-1,020
-50% -$75.7K 0.06% 26
2017
Q1
$149K Sell
2,040
-498
-20% -$34.9K 0.15% 18
2016
Q4
$166K Hold
2,538
0.13% 16
2016
Q3
$188K Hold
2,538
0.15% 23
2016
Q2
$185K Hold
2,538
0.15% 20
2016
Q1
$180K Buy
2,538
+498
+24% +$33.1K 0.16% 21
2015
Q4
$136K Buy
+2,040
New +$136K 0.13% 18

Other funds holding CL

Stuart Chaussee & Associates's CL Position: Q4 2017 in Review

Stuart Chaussee & Associates sold out of Colgate-Palmolive (CL) in Q4 2017, closing a stake of 500 shares — an estimated $36K sold.

Stuart Chaussee & Associates first reported a position in CL in Q4 2015 and held it in 8 quarters. The position peaked at $188K in Q3 2016. 1,474 funds tracked by Wall St. Rank hold CL as of Q4 2017.

  • Stuart Chaussee & Associates reported no remaining Colgate-Palmolive position as of Q4 2017 after selling out during the quarter.
  • Stuart Chaussee & Associates sold 500 Colgate-Palmolive shares in Q4 2017, an estimated $36K.
  • Stuart Chaussee & Associates first reported a position in Colgate-Palmolive in Q4 2015 and held it in 8 quarters.
  • Stuart Chaussee & Associates's Colgate-Palmolive position peaked at $188K in Q3 2016.
  • 1,474 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2017.

Based on Stuart Chaussee & Associates's 13F filing for Q4 2017, filed 2 Feb 2018.